Carcinoid heart disease: a guide for screening and timing of surgical intervention

about

Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.Carcinoid-syndrome: recent advances, current status and controversies.

P2860

Q49432207-2B4CDA92-11C4-40D9-A208-5398BB50BACD Q50094023-562CBBB8-25E2-439D-83F2-4CDD27AEFD22

P2860

Carcinoid heart disease: a guide for screening and timing of surgical intervention

Item

http://www.wikidata.org/entity/Q39385108

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Carcinoid heart disease: a guide for screening and timing of surgical intervention

@en

Carcinoid heart disease: a guide for screening and timing of surgical intervention.

@nl

type

Item

label

Carcinoid heart disease: a guide for screening and timing of surgical intervention

@en

Carcinoid heart disease: a guide for screening and timing of surgical intervention.

@nl

prefLabel

Carcinoid heart disease: a guide for screening and timing of surgical intervention

@en

Carcinoid heart disease: a guide for screening and timing of surgical intervention.

@nl

P1476

Carcinoid heart disease: a guide for screening and timing of surgical intervention

@en

P2093

C A de Groot

http://www.w3.org/2001/XMLSchema#string

E A Hart

http://www.w3.org/2001/XMLSchema#string

G D Valk

http://www.w3.org/2001/XMLSchema#string

K M Dreijerink

http://www.w3.org/2001/XMLSchema#string

M E Tesselaar

http://www.w3.org/2001/XMLSchema#string

R C A Meijer

http://www.w3.org/2001/XMLSchema#string

S A J Chamuleau

http://www.w3.org/2001/XMLSchema#string

P2860

Carcinoid heart disease: presentation, diagnosis, and management

Complications from carcinoid syndrome: review of the current evidence

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide

Current status of gastrointestinal carcinoids.

Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients.

P2888

s12471-017-1011-2

P304

471-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12471-017-1011-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

T Meijs

Timion A Meijs

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28631210

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery

P932

5571595

http://www.w3.org/2001/XMLSchema#string

Carcinoid heart disease: a guide for screening and timing of surgical intervention

about

P2860

P2860

Carcinoid heart disease: a guide for screening and timing of surgical intervention

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932